New Advances on Endocrine, Metabolic and Immune Diseases is a leading international journal
containing basic translational, and clinical contents of endocrinology, metabolism, and immunology.
Written by internationally renowned basic and clinical academics and researchers, it is dedicated to
clinicians, researchers, and students working in any biological or medical discipline.
Subjects covered include endocrinology, diabetes mellitus, cardiology, hypertension, nephrology,
atherosclerosis, cardiac insufficiency, metabolism, inflammation, autoimmunity, immune response to
infections, and parasitology. This journal aims to span the full spectrum of translational research from
basic science to clinical science, covering a critical evaluation of new treatments and patient-
population-related outcomes. It provides up-to-date coverage of novel developments enhancing our
understanding of the epidemiology, pathophysiology, diagnosis, and treatment of endocrine, metabolic
and immune system diseases and gives insight into the metabolic basis of other human diseases.
Particular interests include mini-reviews, in-depth reviews, scientific basic reports, scientific hypothesis,
results of clinical and epidemiologic trials, new clinical or laboratory methods, systematic reviews and
meta-analysis, datasets/software/applications of interest within the journal's scope, both clinical and
epidemiologic studies, clinical practice guidelines and perspectives/commentaries on new
Manuel Velasco Central University of Venezuela Caracas (Venezuela) Biography
Biography of Manuel Velasco
Manuel Velasco, M.D., is a Professor of Pharmacology at the Central University of
Venezuela, School of Medicine, and Director of Clinical Pharmacology Unit (CPU) at the
Vargas School of Medicine in Caracas, Venezuela. Before joining to CPU, he obtained his
Fellowship in Medicine at Emory University School of Medicine, Atlanta, USA. Dr. Velasco
obtained his Fellowship at the Royal College of Physicians of Edinburgh. and acquired
considerable experience in the areas of nuclear transfer, embryonic stem cells, embryo
micromanipulation and state-of-the-art genetic engineering techniques in Biostatistics,
radioisotopes and advanced Clinical pharmacology in the Royal College of Physicians in
Edinburgh, Scotland, UK.
He has contributed significantly in the understanding of Endogenous Amines in blood
pressure control, and his observations on anti-hypertensive drugs have helped spark the
renewed interest in clinical pharmacology of this disease.
He has also served as a member of the Editorial Board or Reviewer ad hoc of the
following international journals: Hypertension, the Journal of Cardiovascular
Pharmacology, Clinical Pharmacology and Therapeutics, the Journal of Hypertension , the
Journal of Clinical Pharmacology. He also serves as a Member of the Editorial Board of
the American Journal of Therapeutics and reviewer ad hoc of the Journal of Hypertension
and the Journal of Clinical Pharmacology.
Dr. Velasco has edited several international congress series of Elsevier(The Netherlands)
In the area of Cardiovascular Physiology, Hypertension, Clinical Pharmacology and
Therapeutics and Internal Medicine.
Among his activities have being the founding of numerous scientific societies: Venezuelan
Society of Pharmacology, Venezuelan Society of Clinical Pharmacology, Interamerican
Society of Clinical Pharmacology, Latinamerican Society of Hypertension, Venezuelan
Society of Hypertension and Interamerican Society of Diabetes
He also serves as Editor-in-Chief of two of the most accredited Scientific Journals in Latin
America: “Archivos Venezolanos de Farmacología y Terapeutica” y la “Revista
Latinoamericana de Hipertensión”. Dr. Velasco is one of the top scientists involved in
Hypertension and Clinical Pharmacology combining years of extensive research and
Dr Velasco is an author and co-author of many scientific papers in the field of
cardiovascular diseases and metabolic syndrome diseases(Hypertension, prediabetes,
diabetes, obesity, insulin resistance, dyslipidemias, etc)